Article Impact Level: HIGH Data Quality: STRONG Summary of JAMA, 331(18), 1565. Dr. Wayne A. Ray et al. Points The study aimed to compare the risk of severe bleeding events in atrial fibrillation patients on anticoagulants...
Most Recent Articles
Enhancing Walking Performance in PAD: NR and Resveratrol Clinical Trial
Article Impact Level: HIGH Data Quality: STRONG Summary of Nature Communications, 15(1), 5046. Dr. Mary M. McDermott et al. Points Individuals with lower extremity peripheral artery disease (PAD) face heightened oxidative stress...
Novel Hydrogel Therapy for Post-MI Arrhythmia: Collagen-PEDOT:PSS Approach
Article Impact Level: HIGH Data Quality: STRONG Summary of Advanced Materials, 2403642. Kaveh Roshanbinfar et al. Points Myocardial infarction (MI) often leads to sudden cardiac deaths (SCD), with implantable cardioverter...
AGTR1 Inhibition in AML: Balancing Chemotherapy Efficacy and Cardiotoxicity
Article Impact Level: HIGH Data Quality: STRONG Summary of Science Translational Medicine, 16(752), eadl5931. Dr. Yi Pan et al. Points Angiotensin II receptor type 1 (AGTR1) has been identified as a common target in acute myeloid...
Comparing ASCVD Risk Estimates: Impact of PREVENT Equations on Statin Therapy Recommendations
Article Impact Level: HIGH Data Quality: STRONG Summary of JAMA Internal Medicine. Dr. Timothy S. Anderson et al. Points In 2023, the American Heart Association introduced the PREVENT equations to estimate 10-year atherosclerotic...